Published March 12, 2021 | Version v1

Accompanying data - "The quandary of DNA-based treatment assessment in de novo metastatic prostate cancer in the era of precision oncology"

  • 1. Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
  • 2. Department of Oncology, Oslo University Hospital, Oslo, Norway
  • 3. Department of Radiology, Oslo University Hospital, Oslo, Norway
  • 4. Department of Cancer Biology, Thomas Jefferson University, Philadelphia, USA
  • 5. Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark

Description

Molecular data of case report described in the manuscript "The quandary of DNA-based treatment assessment in de novo metastatic prostate cancer in the era of precision oncology".

Files

PCa_data_zenodo.zip

Files (30.5 MB)

Name Size Download all
md5:77267cbbf88ac1bc0b55c0ed03a17b99
30.5 MB Preview Download